Dermatology Doctors in Mishawaka, IN Accepting Medicare

3 Dermatology doctors found. Showing 1 - 3

Dr. Ellen Cunningham, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1802 Day Rd, Mishawaka, IN 46545 Phone: 574-204-7200    Fax: 574-252-0633

Dr. Todd W Rozycki, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1802 Day Rd, Mishawaka, IN 46545 Phone: 574-204-7200    Fax: 574-252-0633

Miles Burton Andrew, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 230 E Day Rd, Suite 130, Mishawaka, IN 46545 Phone: 574-335-7650    Fax: 574-335-0736

News Archive

NIH study finds that MDMA drug can be more dangerous in hot, crowded settings

A moderate dose of MDMA, commonly known as Ecstasy or Molly, that is typically nonfatal in cool, quiet environments can be lethal in rats exposed to conditions that mimic the hot, crowded, social settings where the drug is often used by people, a study finds.

Death by drink on the rise in the UK

According to a new study Britain now has experienced the sharpest increase in death rates from liver cirrhosis in western Europe; and that not so jolly news comes just days after some of the heaviest drinking of the year.

Spectrum Pharmaceuticals ranked #23 on Deloitte's Technology Fast 500

Spectrum Pharmaceuticals, Inc., a biotechnology company with fully integrated commercial and drug development operations with a primary focus in oncology, today announced that it ranked #23 on Technology Fast 500™, Deloitte's ranking of 500 of the fastest growing technology, media, telecommunications, life sciences and clean technology companies in North America. Rankings are based on percentage of fiscal year revenue growing during the period from 2005-2009. Spectrum Pharmaceuticals grew 6,490% during this period.

2009 Harris Interactive RQ Study finds decline in reputation of Pharmaceuticals

After hitting rock bottom during the height of greed, bailouts, and the economic crisis in 2008, the American public's perceptions of the reputation of corporate America seem to be bouncing back. This, according to the findings of the 2009 Harris Interactive RQ Study, which measures the reputations of the 60 Most Visible Companies in the U.S.

Peramivir drug safe, effective at alleviating influenza symptoms

An analysis of phase 2 and phase 3 clinical trials shows that a single injected dose of the neuraminidase inhibitor (NAI) peramivir is safe and effective at alleviating influenza symptoms, including fever and viral shedding, when administered within 48 hours of the onset of symptoms.

Read more Medical News

› Verified 2 days ago